JCIA
ADMA icon

Jackson Creek Investment Advisors’s ADMA Biologics ADMA Stock Holding History

Jackson Creek Investment Advisors’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-88,272
Closed -$1.75M – 309
2025
Q1 		$1.75M Sell
88,272
-59
-0.1% -$1.02K 0.56% 21
2024
Q4 		$1.51M Sell
88,331
-2,739
-3% -$51.5K 0.46% 99
2024
Q3 		$1.82M Sell
91,070
-29,712
-25% -$462K 0.54% 28
2024
Q2 		$1.35M Sell
120,782
-79,128
-40% -$664K 0.49% 36
2024
Q1 		$1.32M Buy
+199,910
New +$1.09M 0.47% 33

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Jackson Creek Investment Advisors's ADMA Position: Q2 2025 in Review

Jackson Creek Investment Advisors sold out of ADMA Biologics (ADMA) in Q2 2025, closing a stake of 88,272 shares — an estimated $1.75M sold.

Jackson Creek Investment Advisors first reported a position in ADMA in Q1 2024 and held it in 5 quarters. The position peaked at $1.82M in Q3 2024. 368 funds tracked by Wall St. Rank hold ADMA as of Q2 2025.

  • Jackson Creek Investment Advisors reported no remaining ADMA Biologics position as of Q2 2025 after selling out during the quarter.
  • Jackson Creek Investment Advisors sold 88,272 ADMA Biologics shares in Q2 2025, an estimated $1.75M.
  • Jackson Creek Investment Advisors first reported a position in ADMA Biologics in Q1 2024 and held it in 5 quarters.
  • Jackson Creek Investment Advisors's ADMA Biologics position peaked at $1.82M in Q3 2024.
  • 368 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2025.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.